- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/5513 - 1,4-Benzodiazepines, e.g. diazepam
Patent holdings for IPC class A61K 31/5513
Total number of patents in this class: 1480
10-year publication summary
|
105
|
113
|
112
|
166
|
138
|
133
|
157
|
142
|
100
|
39
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19803 |
38 |
| Bristol-myers Squibb Company | 4897 |
34 |
| Alkermes Pharma Ireland Limited | 272 |
27 |
| Enanta Pharmaceuticals, Inc. | 428 |
21 |
| Jazz Pharmaceuticals Research UK Limited | 176 |
21 |
| Nippon Chemiphar Co., Ltd. | 228 |
18 |
| GW Research Limited | 236 |
16 |
| Ovid Therapeutics Inc | 154 |
16 |
| Neurelis, Inc. | 51 |
15 |
| Boehringer Ingelheim International GmbH | 4701 |
14 |
| Ayala Pharmaceuticals Inc. | 18 |
13 |
| Novartis AG | 10927 |
11 |
| The Johns Hopkins University | 5637 |
11 |
| io Therapeutics, Inc. | 117 |
11 |
| Clexio Biosciences Ltd. | 101 |
11 |
| F. Hoffmann-La Roche AG | 7920 |
10 |
| Pfizer Inc. | 3358 |
10 |
| Dana-Farber Cancer Institute, Inc. | 2548 |
10 |
| Aquestive Therapeutics, Inc. | 178 |
10 |
| Immunome Inc. | 55 |
9 |
| Other owners | 1154 |